SWA
Shockwave Med
Stock
Stock
ISIN: US82489T1043
Ticker: SWAV
US82489T1043
SWAV
Price
Price
CHART BY
Frequently asked questions
What is Shockwave Med's market capitalization?
The market capitalization of Shockwave Med is $12.57B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Shockwave Med's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Shockwave Med is 78.40. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Shockwave Med?
Shockwave Med's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $4.27. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Shockwave Med's stock?
Currently, 1 analysts cover Shockwave Med's stock, with a consensus target price of $335.00. Analyst ratings provide insights into the stock's expected performance.
What is Shockwave Med's revenue over the trailing twelve months?
Over the trailing twelve months, Shockwave Med reported a revenue of $787.97M.
What is the EBITDA for Shockwave Med?
Shockwave Med's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $177.21M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Shockwave Med?
Shockwave Med has a free cash flow of $166.14M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Shockwave Med have, and what sector and industry does it belong to?
Shockwave Med employs approximately 1,468 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Shockwave Med's shares?
The free float of Shockwave Med is 36.73M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $12.57B
- EPS (TTM)
- $4.27
- Free Float
- 36.73M
- P/E ratio (TTM)
- 78.40
- Revenue (TTM)
- $787.97M
- EBITDA (TTM)
- $177.21M
- Free Cashflow (TTM)
- $166.14M
Pricing
- 52W span
- $167.86$363.14
Analyst Ratings
The price target is $335.00 and the stock is covered by 1 analysts.
Buy
0
Hold
1
Sell
0
Information
Shockwave Medical, Inc. operates as a medical device company, which concentrates on developing and commercializing products intended to transform the way classified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.
- Employees
- 1,468
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US82489T1043
- Primary Ticker
- SWAV